Ubs Asset Management Americas Inc Eye Point Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 90,349 shares of EYPT stock, worth $584,558. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,349
Previous 68,630
31.65%
Holding current value
$584,558
Previous $548,000
22.81%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$53.9 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$43.9 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$37.2 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$26.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$24.6 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $220M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...